A Long-Term, Open-Label Study to Evaluate the Safety and Tolerability of Brexpiprazole as Maintenance Treatment in Adults with Schizophrenia

BACKGROUND: Brexpiprazole is a serotonin–dopamine activity modulator with efficacy in acute schizophrenia and relapse prevention. The aim of this Phase 3, multicenter study was to assess the long-term safety, tolerability, and efficacy of treatment with brexpiprazole flexible-dose 1–4 mg/d. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Forbes, Andy, Hobart, Mary, Ouyang, John, Shi, Lily, Pfister, Stephanie, Hakala, Mika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Regular Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5932477/
https://www.ncbi.nlm.nih.gov/pubmed/29415258
http://dx.doi.org/10.1093/ijnp/pyy002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5932477/
https://www.ncbi.nlm.nih.gov/pubmed/29415258
http://dx.doi.org/10.1093/ijnp/pyy002

Ejemplares similares